This study aims to evaluate the efficacy and safety of applying pulse electrical stimulation around eye in dry eye disease patients who are scheduled for LASEK surgery.

Duration of study period (per participant): Screening period (0-14 days), Intervention period (12 weeks), F/U period (2 weeks) Patient needs to visit site at least 9 times (Screening, baseline, V1, V2, V3, Tele-visit, V4, V5, F/U Tele-visit). Baseline visit will be done on the day of surgery. Visit 1, 2, 3, Tele-visit, 4, 5, F/U Tele-visit is 1 day, 3 days, 1 weeks, 2 weeks, 4 weeks, 12 weeks and 16weeks after baseline visit.

Inclusion Criteria:

• Participants must be 19 to 60 years of age, at the time of screening
• Those who are scheduled to get LASEK surgery
• According to the guidelines for diagnosing dry eye syndrome of Korean Corneal Disease Study Group, those who fall under Grade II or higher
• Those with an OSDI score of 13 or higher
• A person who has no pregnancy plan during the clinical trial period and has agreed to an effective contraceptive plan for Women of child bearing potential (WOCBP) by a doctor
• A person who voluntarily agreed to participate in this clinical trial

Exclusion Criteria:

Patients who meet any of the exclusion criteria are excluded from this clinical trial.

• A person with an uncontrollable systemic chronic disease (diabetes mellitus)
• Those who are allergic to drugs such as Fluorescein Solution or ophthalmic anesthetics
• In a case where there is a history of receiving ophthalmic surgery known to affect the tear layer within the last 6 months (e.g., Cataract, Pterygium surgery)
• A person who takes systemic drugs (e.g., tetracycline derivatives, antihistamine, isotretinoin)
• A person who has eyelid diseases or structural abnormalities
• A person with acute eye infection or inflammation of the eyeball not related to Meibomian gland dysfunction
• A person with abnormalities in the eyelids or eyelashes
• A person with an eye condition or ophthalmic disease that is considered unsuitable for surgery (e.g., detachment of the retina, cataract)
• Pregnant or lactating women
• Those who can't understand or read the consent form of this clinical trial (e.g., illiterate or foreigners)
• Any other cases that PI considers hard to participate in this clinical trial (e.g., heart-related problems, seizure, epilepsy. Patients transplanted metal or electronic device in head & neck. Patient suffering from unknown pain. Patients who are warned not to use our clinical trial device or is prohibited from using it (e.g., pacemaker user).)